OBIO Orchestra BioMed Holdings, Inc.
Healthcare$3.97-2.22%ClosedMarket Cap: $237.7M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
3.06
P/S
7.43
EV/EBITDA
-3.98
DCF Value
$-6.55
FCF Yield
-22.7%
Div Yield
0.0%
Margins & Returns
Gross Margin
99.3%
Operating Margin
-168.0%
Net Margin
-167.0%
ROE
-138.0%
ROA
-54.3%
ROIC
-62.6%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $110.0K | 16.4% | $-22.1M | $-20.7M | $— | — |
| Q4 null | $30.9M | 99.8% | $6.8M | $6.2M | $— | — |
| FY null | $33.5M | 99.4% | $-51.8M | $-52.7M | $— | — |
| Q3 null | $861.0K | 94.3% | $-20.3M | $-20.8M | $— | — |
| Q2 null | $836.0K | 94.5% | $-19.3M | $-19.4M | $— | — |
| Q1 null | $868.0K | 94.9% | $-18.9M | $-18.8M | $— | — |
| Q4 null | $253.0K | 77.1% | $-16.7M | $-16.2M | $— | — |
| FY null | $2.6M | 92.3% | $-64.3M | $-61.0M | $— | — |
| Q3 null | $987.0K | 93.1% | $-16.3M | $-15.4M | $— | — |
| Q2 null | $778.0K | 94.3% | $-16.9M | $-16.0M | $— | — |
| Q1 null | $620.0K | 82.6% | $-14.4M | $-13.5M | $— | — |
| Q4 2023 | $262.0K | 68.3% | $-12.5M | $-12.8M | $-0.36 | — |